Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 182

Similar articles for PubMed (Select 10507275)

1.

Use patterns for antipsychotic medications in medicaid patients with schizophrenia.

McCombs JS, Nichol MB, Stimmel GL, Shi J, Smith RR.

J Clin Psychiatry. 1999;60 Suppl 19:5-11; discussion 12-3.

PMID:
10507275
2.
3.

The impact of atypical antipsychotic medications on the use of health care by patients with schizophrenia.

Chen L, McCombs JS, Park J.

Value Health. 2008 Jan-Feb;11(1):34-43. doi: 10.1111/j.1524-4733.2007.00212.x.

PMID:
18237358
4.

Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.

Morrato EH, Dodd S, Oderda G, Haxby DG, Allen R, Valuck RJ.

Clin Ther. 2007 Jan;29(1):183-95.

PMID:
17379060
5.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
6.

Antipsychotic medication use patterns and associated costs of care for individuals with schizophrenia.

Loosbrock DL, Zhao Z, Johnstone BM, Morris LS.

J Ment Health Policy Econ. 2003 Jun;6(2):67-75.

PMID:
14578539
7.

Treatment adherence associated with conventional and atypical antipsychotics in a large state Medicaid program.

Menzin J, Boulanger L, Friedman M, Mackell J, Lloyd JR.

Psychiatr Serv. 2003 May;54(5):719-23.

PMID:
12719504
8.
9.

Prevalence, trends, and factors associated with antipsychotic polypharmacy among Medicaid-eligible schizophrenia patients, 1998-2000.

Ganguly R, Kotzan JA, Miller LS, Kennedy K, Martin BC.

J Clin Psychiatry. 2004 Oct;65(10):1377-88.

PMID:
15491242
10.

Antipsychotic exposure and type 2 diabetes among patients with schizophrenia: a matched case-control study of California Medicaid claims.

Lambert BL, Chou CH, Chang KY, Tafesse E, Carson W.

Pharmacoepidemiol Drug Saf. 2005 Jun;14(6):417-25.

PMID:
15786516
11.

Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia.

Gilmer TP, Dolder CR, Lacro JP, Folsom DP, Lindamer L, Garcia P, Jeste DV.

Am J Psychiatry. 2004 Apr;161(4):692-9.

PMID:
15056516
12.

Classifying patients by antipsychotic adherence patterns using latent class analysis: characteristics of nonadherent groups in the California Medicaid (Medi-Cal) program.

Ahn J, McCombs JS, Jung C, Croudace TJ, McDonnell D, Ascher-Svanum H, Edgell ET, Shi L.

Value Health. 2008 Jan-Feb;11(1):48-56. doi: 10.1111/j.1524-4733.2007.00214.x.

PMID:
18237360
13.

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.

Lewis SW, Davies L, Jones PB, Barnes TR, Murray RM, Kerwin R, Taylor D, Hayhurst KP, Markwick A, Lloyd H, Dunn G.

Health Technol Assess. 2006 May;10(17):iii-iv, ix-xi, 1-165.

14.

Racial disparities in antipsychotic prescription patterns for patients with schizophrenia.

Kuno E, Rothbard AB.

Am J Psychiatry. 2002 Apr;159(4):567-72.

PMID:
11925294
15.

Outpatient antipsychotic treatment and inpatient costs of schizophrenia.

Marcus SC, Olfson M.

Schizophr Bull. 2008 Jan;34(1):173-80. Epub 2007 Jun 19.

16.

Olanzapine versus risperidone in the treatment of schizophrenia : a comparison of costs among Texas Medicaid recipients.

Rascati KL, Johnsrud MT, Crismon ML, Lage MJ, Barber BL.

Pharmacoeconomics. 2003;21(10):683-97.

PMID:
12828491
17.

Ethnicity and prescription patterns for haloperidol, risperidone, and olanzapine.

Opolka JL, Rascati KL, Brown CM, Gibson PJ.

Psychiatr Serv. 2004 Feb;55(2):151-6.

PMID:
14762239
18.

The effect of adjunctive mood stabilizers on antipsychotic utilization pattern and health resource utilization for Medicaid enrollees with schizophrenia.

Chen H, Kennedy WK, Dorfman JH, Fincham JE, Reeves J, Martin BC.

Curr Med Res Opin. 2007 Jun;23(6):1351-65. Epub 2007 May 1.

PMID:
17559734
19.

Cost of treating bipolar disorder in the California Medicaid (Medi-Cal) program.

Li J, McCombs JS, Stimmel GL.

J Affect Disord. 2002 Sep;71(1-3):131-9.

PMID:
12167509
20.

Hyperlipidemia following treatment with antipsychotic medications.

Olfson M, Marcus SC, Corey-Lisle P, Tuomari AV, Hines P, L'Italien GJ.

Am J Psychiatry. 2006 Oct;163(10):1821-5.

PMID:
17012695
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk